Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trialNatalie Staplin, Vicki Adell, SYA Ng et al.|The Lancet Diabetes & Endocrinology|2023Cited by 94
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEYGreco Mark Malijan, William G. Herrington, Rebecca J. Sardell et al.|American Journal of Kidney Diseases|2025Cited by 8
Plain language summary of a study looking at the effect of empagliflozin treatment in patients with chronic kidney diseaseAlistair Roddick, Sibylle J. Hauske, Anne Whitehouse et al.|Clinical Kidney Journal|2024Cited by 0
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEYGreco B. Malijan, William G. Herrington, Rebecca J. Sardell et al.|Unknown|2026Cited by 0